Dr. Liron Pantanowitz, the Director of Pathology Informatics, the Pathology Informatics Fellowship and Cytopathology at the University of Pittsburgh Medical Center (UPMC Digital Pathology) Shadyside, is conducting research on practical applications of the Augmentiqs system within the pathology workflow. The research will seek to quantify the improvements that Augmentiqs offers pathology labs; looking at quantitative tools to enhance workflow and diagnostics.
In addition to studying existing toolsets already available within the Augmentiqs system, UPMC may seek to develop new applications that will be deployed within the Augmentiqs solution via its developer’s Open API. The unique capability of Augmentiqs to deploy 3rd party digital pathology software applications within the existing microscope could act as a cost-efficient and easy to implement solution for labs seeking the benefit of digital pathology without the heavy investment in scanning infrastructure.
In particular, UPMC digital pathology director Dr. Liron Pantanowitz is interested in utilizing the augmented reality capabilities of the Augmentiqs system as an integrated component of quantitative scoring of IHC tissue samples. The ability to quickly and accurately segment, count and quantify IHC markers in tissue samples can be one of the most significant advancements in digital pathology.
In addition to quantitative analysis, UPMC is testing the Augmentiqs telepathology solution as a method for real-time consultation between its multiple satellite locations.
Initial findings of the research should be ready towards the end of 2019.
About Dr. Pantanowitz:
Dr. Pantanowitz is the Director of Pathology Informatics, the Pathology Informatics Fellowship and Cytopathology at the University of Pittsburgh Medical Center (UPMC) Shadyside, USA. He is an Associate Professor of Pathology and of Biomedical Informatics at the University of Pittsburgh, USA. He is an editor in chief of the Journal of Pathology Informatics. Dr. Pantanowitz has published over 500 publications in the areas of pathology and digital pathology, and has been cited by nearly 7,000 publications.